Back to Search
GARY LICHTENSTEIN, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1255321600Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
0101032464(VA)
Research & Publications (20)
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials.
PMID 19392858·Aliment Pharmacol Ther·2009
3-trial
Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis.
PMID 19035972·Aliment Pharmacol Ther·2009
4-observational
Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
PMID 18477967·Rev Gastroenterol Disord·2008
6-review
Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis--methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa.
PMID 18532992·Aliment Pharmacol Ther·2008
6-review
MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
PMID 18363894·Aliment Pharmacol Ther·2008
2-rct
Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis.
PMID 17551835·Dig Dis Sci·2008
4-observational
Review article: Bowel preparation for colonoscopy--the importance of adequate hydration.
PMID 17697197·Aliment Pharmacol Ther·2007
6-review
Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
PMID 17234558·Clin Gastroenterol Hepatol·2007
3-trial
Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation.
PMID 17983368·Aliment Pharmacol Ther·2007
4-observational
American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
PMID 16530531·Gastroenterology·2006
8-other
Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis.
PMID 16940876·J Clin Gastroenterol·2006
6-review
Prevention and treatment of osteoporosis in inflammatory bowel disease.
PMID 16917235·Inflamm Bowel Dis·2006
6-review
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
PMID 16678077·Clin Gastroenterol Hepatol·2006
4-observational
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
PMID 16606351·Am J Gastroenterol·2006
4-observational
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
PMID 16530532·Gastroenterology·2006
6-review
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.
PMID 15825070·Gastroenterology·2005
3-trial
Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
PMID 15984959·Am J Gastroenterol·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 COMMERCE RD, 413
STAUNTON, VA 24401 - Phone
- (540) 886-0988
Quick Facts
- NPI
- 1255321600
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile